Close Menu

NEW YORK — Investment banks William Blair, Canaccord Genuity, and BTIG on Monday initiated coverage of newly public diagnostics firm Biodesix, with ratings ranging from Buy to Outperform.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.